Arkolith/Insider Trading/PTGX/Form 4

Patel Dinesh V PH D

President and CEO, DirectorProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Apr 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2026Gift(G)1K—$0523K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-048572) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML